AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31178499 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for oral medication (no mental burden)
Number of subjects: 524
Study 31178499 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for oral medication (neither)
Number of subjects: 524
Study 31178499 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of mental burden by eliminating 1 medication
Number of subjects: 524
Study 28613121 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) system using mobile phones for data collection
Number of subjects: 25089
Study 28613121 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's groups intervention
Number of subjects: 25089
Study 28613121 — intervention group
Group type: EXPERIMENTAL
Intervention: Food transfers intervention
Number of subjects: 25089
Study 28613121 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash transfers intervention
Number of subjects: 25089
Study 26433819 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib (150 mg twice-daily) and Trametinib (2 mg once-daily)
Number of subjects: 704
Study 26433819 — intervention group
Group type: COMPARATOR
Intervention: Vemurafenib (960 mg twice-daily)
Number of subjects: 704
Study 26433819 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib plus Trametinib
Number of subjects: 704
Study 23611915 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuraxial block
Number of subjects: 8351
Study 23611915 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural with general anaesthesia
Number of subjects: 8351
Study 21863678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone spray
Number of subjects: 42
Study 21863678 — intervention group
Group type: COMPARATOR
Intervention: NSS (Normal Saline Solution)
Number of subjects: 42
Study 19856872 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex compound of Cu(II) (dinitrate (V) di (3,4,5‐trimethyl‐N1‐pyrazol‐kappaN2) copper (II))
Number of subjects: 0
Study 19856872 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Cu(II) compound)
Number of subjects: 0
Study 16960473 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (a selective serotonin reuptake inhibitor)
Number of subjects: 21
Study 16960473 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (5-HT1a receptor-specific challenge)
Number of subjects: 21
Study 16960473 — intervention group
Group type: COMPARATOR
Intervention: Citalopram and Buspirone
Number of subjects: 21
Study 15064089 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen replacement therapy
Number of subjects: 0
Study 10227067 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg terfenadine
Number of subjects: 10
Study 10227067 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 10
Study 8818855 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg once daily for 3 days)
Number of subjects: 4500
Study 8818855 — intervention group
Group type: COMPARATOR
Intervention: Comparator agents (amoxycillin, co-amoxiclav, cefixime, cefaclor, clarithromycin, erythromycin, penicillin V, cloxacillin, or roxithromycin)
Number of subjects: 4500
Study 8818855 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 4500
Study 8818855 — intervention group
Group type: COMPARATOR
Intervention: Comparator agents
Number of subjects: 4500
Study 2004477 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms i.v. in bolus) plus rhEPO (40 U/kg in constant infusion for 30 min)
Number of subjects: 14
Study 2004477 — intervention group
Group type: COMPARATOR
Intervention: GHRH (100 micrograms i.v. in bolus)
Number of subjects: 14
Study 6338155 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 1086
Study 6338155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1086
Study 6338155 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 1086
Study 29442476 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ferritin and iron levels at 12 gestational weeks in GDM group
Number of subjects: 362
Study 29442476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-off values of serum ferritin and iron at 12 gestational weeks
Number of subjects: 362
Study 29442476 — intervention group
Group type: EXPERIMENTAL
Intervention: Early detection of serum iron and ferritin levels
Number of subjects: 362
Study 28866468 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride
Number of subjects: 66
Study 28866468 — intervention group
Group type: COMPARATOR
Intervention: Placebo (blue-tinted water)
Number of subjects: 66
Study 27658925 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (30 min of moderate intensity walking and stretching exercises for 16 months)
Number of subjects: 29
Study 27658925 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 29
Study 27658925 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 29
Study 24717427 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-naive children
Number of subjects: 496
Study 24717427 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-experienced children
Number of subjects: 496
Study 24717427 — intervention group
Group type: COMPARATOR
Intervention: HIV-uninfected controls
Number of subjects: 496
Study 22076595 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum for a minimum of 90 min/day (n = 102)
Number of subjects: 201
Study 22076595 — intervention group
Group type: COMPARATOR
Intervention: Printed nutrition information only (n = 99)
Number of subjects: 201
Study 21209993 — intervention group
Group type: EXPERIMENTAL
Intervention: Denzir (DZ) system restorations
Number of subjects: 18
Study 21209993 — intervention group
Group type: COMPARATOR
Intervention: In‐Ceram Zirconia (InZ) system restorations
Number of subjects: 18
Study 18495964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (100 mg of elemental iron)
Number of subjects: 110
Study 18495964 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 110
Study 18495964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (various doses ranging from 20 to 500 mg)
Number of subjects: 110
Study 18495964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 110
Study 15845681 — intervention group
Group type: EXPERIMENTAL
Intervention: N(2)O anesthesia
Number of subjects: 35
Study 15845681 — intervention group
Group type: COMPARATOR
Intervention: TIVA
Number of subjects: 35
Study 13680198 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngo‐oesophageal scintigraphy (OPES)
Number of subjects: 16
Study 14590217 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulating head injury with warning
Number of subjects: 0
Study 14590217 — intervention group
Group type: COMPARATOR
Intervention: Simulating head injury without warning
Number of subjects: 0
Study 14590217 — intervention group
Group type: COMPARATOR
Intervention: Normal performance
Number of subjects: 0
Study 14590217 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve malingerers
Number of subjects: 0
Study 14590217 — intervention group
Group type: EXPERIMENTAL
Intervention: Warned malingerers
Number of subjects: 0
Study 14590217 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-choice measure
Number of subjects: 0
Study 8555470 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (45 mg/kg/d for 4 consecutive days)
Number of subjects: 10
Study 1829969 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination, chest radiography, and electrocardiography
Number of subjects: 81
Study 1829969 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined clinical examination, radiography, and electrocardiography
Number of subjects: 81
Study 1829969 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 81
Study 6823889 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian meals containing contamination iron
Number of subjects: 12
Study 6823889 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro method for measuring isotopic exchange
Number of subjects: 12
Study 6823889 — intervention group
Group type: EXPERIMENTAL
Intervention: Consideration of contamination iron in iron absorption measurements
Number of subjects: 12
Study 31956250 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic esophagectomy
Number of subjects: 0
Study 31956250 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study 30254212 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF fusions identified in the study
Number of subjects: 60
Study 30254212 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenously expressed BRAF fusions
Number of subjects: 60
Study 30254212 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF fusions (including SEPT3‐BRAF)
Number of subjects: 60
Study 29118383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 (1 × 108 colony forming units)
Number of subjects: 65
Study 29118383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 29118383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri density
Number of subjects: 65
Study 29118383 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli density
Number of subjects: 65
Study 26409670 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual captopril
Number of subjects: 212
Study 26409670 — intervention group
Group type: COMPARATOR
Intervention: Oral captopril
Number of subjects: 212
Study 25365798 — intervention group
Group type: COMPARATOR
Intervention: Intracranial area (ICA) measurement
Number of subjects: 42
Study 23144438 — intervention group
Group type: EXPERIMENTAL
Intervention: Preperitoneal continuous wound infusion (CWI) with ropivacaine 0.2% at 10 mL/h for 48 hours
Number of subjects: 106
Study 23144438 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (CEI) with ropivacaine 0.2% at 10 mL/h for 48 hours
Number of subjects: 106
Study 23144438 — intervention group
Group type: EXPERIMENTAL
Intervention: Preperitoneal continuous wound infusion (CWI)
Number of subjects: 106
Study 23144438 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (CEI)
Number of subjects: 106
Study 20102913 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol)
Number of subjects: 900
Study 20102913 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (aspirin and clopidogrel)
Number of subjects: 900
Study 18928218 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (1 mg/ml applied at the site of discectomy for 5 minutes)
Number of subjects: 60
Study 18928218 — intervention group
Group type: COMPARATOR
Intervention: Control group (lumbar microdiscectomy without mitomycin C application)
Number of subjects: 60
Study 16086983 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-administered self-help plus minimal therapist contact via e-mail
Number of subjects: 49
Study 16086983 — intervention group
Group type: COMPARATOR
Intervention: Traditional individual cognitive behaviour therapy
Number of subjects: 49
Study 16086983 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Internet group and live group
Number of subjects: 49
Study 12204013 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography, breast physical examination, and instruction on breast self-examination (mammography group)
Number of subjects: 50430
Study 12204013 — intervention group
Group type: COMPARATOR
Intervention: Usual community care after a single breast physical examination and instruction on breast self-examination (usual care group)
Number of subjects: 50430
Study 10614260 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes foot education program (2 sessions conducted by a nurse diabetes educator 3 months apart)
Number of subjects: 100
Study 8349938 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine nasal challenge (1 to 25 mg)
Number of subjects: 58
Study 8349938 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonatopic subjects)
Number of subjects: 58
Study 3770869 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcium supplementation (1 g/day)
Number of subjects: 18
Study 29904005 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Intensity Difference (RID) operator
Number of subjects: 0
Study 29904005 — intervention group
Group type: EXPERIMENTAL
Intervention: RandomFerns and RandomForests classifiers with RID operators
Number of subjects: 0
Study 26751259 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 62
Study 26529960 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia complications during caesarean delivery
Number of subjects: 0
Study 26529960 — intervention group
Group type: EXPERIMENTAL
Intervention: Variations in skill/training and equipment utilization
Number of subjects: 0
Study 22767199 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic steroids (4 injections of 0.3 ml dexamethasone at 8 mg/ml and 0.2 ml hyaluronic acid 0.2%)
Number of subjects: 48
Study 22767199 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (prednisolone, hydroxyethyl starch, pentoxyfylline)
Number of subjects: 48
Study 21607581 — intervention group
Group type: COMPARATOR
Intervention: Water swallow test (WST)
Number of subjects: 62
Study 21607581 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus swallow test + Saliva swallow test (BST + SST)
Number of subjects: 62
Study 21607581 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES)
Number of subjects: 62
Study 17963825 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly fluorouracil (1000 mg/m2/day i.v. for 5 days) plus cisplatin (20 mg/m2/day i.v.)
Number of subjects: 158
Study 17963825 — intervention group
Group type: COMPARATOR
Intervention: Weekly cisplatin (30 mg/m2 i.v.)
Number of subjects: 158
Study 17963825 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly fluorouracil plus cisplatin
Number of subjects: 158
Study 17963825 — intervention group
Group type: COMPARATOR
Intervention: Weekly cisplatin
Number of subjects: 158
Study 16570892 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release of drain following release of tourniquet
Number of subjects: 100
Study 16570892 — intervention group
Group type: COMPARATOR
Intervention: Delayed release of the drain clamp by one hour
Number of subjects: 100
Study 12935406 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwashed shed mediastinal blood (Group 1, n = 30)
Number of subjects: 60
Study 12935406 — intervention group
Group type: COMPARATOR
Intervention: Banked blood (Group 2, n = 30)
Number of subjects: 60
Study 11074080 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional stimuli (pleasant or unpleasant) presented in the same or opposite spatial location to the target
Number of subjects: 18
Study 11074080 — intervention group
Group type: COMPARATOR
Intervention: Neutral picture
Number of subjects: 18
Study 9760148 — intervention group
Group type: EXPERIMENTAL
Intervention: mini‐ICE/ICE chemotherapy
Number of subjects: 43
Study 9760148 — intervention group
Group type: COMPARATOR
Intervention: 5 + 2/7 + 3 chemotherapy
Number of subjects: 43
Study 9760148 — intervention group
Group type: EXPERIMENTAL
Intervention: PBSC transplantation
Number of subjects: 43
Study 8090095 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 89
Study 8090095 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% phenylephrine
Number of subjects: 89
Study 8090095 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 89
Study 3290430 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline irrigation
Number of subjects: 7
Study 3290430 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SC/RP)
Number of subjects: 7
Study 3290430 — intervention group
Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 7
Study 3290430 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 7
Study 30756274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal Response Intervention for Social Motivation (PRISM)
Number of subjects: 0
Study 28763279 — intervention group
Group type: EXPERIMENTAL
Intervention: synthetic feline facial pheromone
Number of subjects: 336
Study 28763279 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 336
Study 25832443 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day of DHA supplementation for two weeks
Number of subjects: 11
Study 25832443 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 11
Study 24064942 — intervention group
Group type: EXPERIMENTAL
Intervention: MICS IOL (Acri.Smart 46S=CT SHERIS 209M)
Number of subjects: 25
Study 24064942 — intervention group
Group type: COMPARATOR
Intervention: SICS IOL (AcriLyc 53N = CT 53N)
Number of subjects: 25
Study 24064942 — intervention group
Group type: EXPERIMENTAL
Intervention: MICS IOL
Number of subjects: 25
Study 24064942 — intervention group
Group type: COMPARATOR
Intervention: SICS IOL
Number of subjects: 25
Study 21421092 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 5mg
Number of subjects: 1434
Study 21421092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1434
Study 18946573 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreamed interlocking nails
Number of subjects: 131
Study 18946573 — intervention group
Group type: COMPARATOR
Intervention: Ender nails
Number of subjects: 131
Study 16597214 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Stones Triple P intervention
Number of subjects: 48
Study 16597214 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 48
Study 12743539 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus 5‐methoxytryptamine (5‐MTT) 1 mg/day orally
Number of subjects: 20
Study 12743539 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (cisplatin plus etoposide)
Number of subjects: 20
Study 10983211 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 30
Study 10983211 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 30
Study 8818067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 4019
Study 8818067 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4019
Study 1543187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (52 pairs)
Number of subjects: 103
Study 1543187 — intervention group
Group type: COMPARATOR
Intervention: Control group (51 pairs)
Number of subjects: 103
Study 3978014 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA 5% cream (Eutectic Mixture of Local Anaesthetics)
Number of subjects: 31
Study 3978014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 30880074 — intervention group
Group type: EXPERIMENTAL
Intervention: Serenoa repens extract (320 mg)
Number of subjects: 354
Study 30880074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 30281182 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (group O2)
Number of subjects: 72
Study 30281182 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% oxygen and 50% nitrous oxide (group N2O)
Number of subjects: 72
Study 30281182 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen with a bolus of 3 μg/kg fentanyl (group FENTANYL)
Number of subjects: 72
Study 27518208 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone Beam CT (CBCT)
Number of subjects: 9
Study 27518208 — intervention group
Group type: COMPARATOR
Intervention: Multislice CT (MSCT)
Number of subjects: 9
Study 25250780 — intervention group
Group type: EXPERIMENTAL
Intervention: Testoviron depot (i.m.: 100 mg/10 days)
Number of subjects: 45
Study 25250780 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone gel (50 mg/die)
Number of subjects: 45
Study 25250780 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (i.m.: 1,000 mg every 6 weeks for the first 6 weeks and then every 12 weeks)
Number of subjects: 45
Study 22765768 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine 10 mg alone
Number of subjects: 18
Study 22765768 — intervention group
Group type: COMPARATOR
Intervention: Ivabradine 10 mg after pre-treatment with phenytoin 150 mg
Number of subjects: 18
Study 21333193 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic occlusion
Number of subjects: 96
Study 21333193 — intervention group
Group type: COMPARATOR
Intervention: Embolization
Number of subjects: 96
Study 17667033 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 240
Study 17667033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 16220082 — intervention group
Group type: EXPERIMENTAL
Intervention: INH-A21 750 mg/kg
Number of subjects: 505
Study 16220082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505
Study 12145376 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal staff management (FSM)
Number of subjects: 106
Study 12145376 — intervention group
Group type: COMPARATOR
Intervention: Conventional staff management (CSM)
Number of subjects: 106
Study 10369059 — intervention group
Group type: EXPERIMENTAL
Intervention: Primed with African American stereotypes
Number of subjects: 60
Study 10369059 — intervention group
Group type: COMPARATOR
Intervention: Primed with neutral words
Number of subjects: 60
Study 7589766 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg sustained-release isradipine
Number of subjects: 34
Study 7589766 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg lacidipine
Number of subjects: 34
Study 7589766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 2289389 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (250 mg, five-day course every six hours)
Number of subjects: 1350
Study 2289389 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin (250 mg, five-day course every six hours)
Number of subjects: 1350
Study 2289389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1350
Study 471860 — intervention group
Group type: EXPERIMENTAL
Intervention: Chapman‐Gray Index
Number of subjects: 0